At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Bristol based Founder operating in the Biotechnology space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Paul Race
Director and Co-Founder of Zentraxa
Paul is Senior Lecturer in Biochemistry at the University of Bristol. From 2014-17 he served as Co-Director of the >£14M Bristol Centre for Synthetic Biology Research (BrisSynBio), was a founding Director of the Bristol BioDesign Institute (BBI) and is academic lead for the >£2.7M EPSRC funded ‘Manufacturing Immortality’ project. His research focuses on the exploitation and manipulation of biological complexes, pathways and networks, en-route to the development of new tools, technologies and products for biotechnology.
Follow Paul Race:
About Zentraxa: Zentraxa has specialise in the design, production and testing of complex novel peptides.
Steven Burston
Co-Founder of Zentraxa
Steve completed his PhD in physical biochemistry at the University of Bristol before being awarded a Prize Fellowship from the Wellcome Trust to work at Yale University and the University of London. He then returned to the University of Bristol where he is a Principal Investigator in the School of Biochemistry.
Follow Steven Burston:
About Zentraxa: Zentraxa has specialise in the design, production and testing of complex novel peptides.
Martin Challand
CTO and Co-Founder of Zentraxa
Leads technology and product research and development. Martin has a master’s degree in Chemistry and a PhD in Chemical Biology, both from the University of Southampton and over 9 years R&D experience across academia and industry working at the interface of chemistry and biology. In 2015 he took up a post-doctoral research position in Synthetic Biology at the University of Bristol to lead the development of the Zentide technology and subsequently co-founded Zentraxa in 2017.
Follow Martin Challand:
About Zentraxa: Zentraxa has specialise in the design, production and testing of complex novel peptides.
Alan Preece
Founder & Consultant of Micrima
Currently Emeritus Professor in the Department of Medical Physics at the University of Bristol and honorary Consultant Clinical Scientist with the United Bristol Healthcare Trust (UBHT). Previously Head of Biophysics Unit, Department of Medical Physics and Professor of Medical Physics, University of Bristol. Alan is a board member of the Bioelectromagnetics Society (USA) and the European Bioelectromagnetics Society, a Fellow of the Institute of Physics and Engineering in Medicine. He has delivered numerous invited lectures worldwide and has received numerous prizes for his work.
Follow Alan Preece:
About Micrima, United Bristol Healthcare Trust, University of Bristol: Developing a breast imaging system using no ionising radiation, no breast compression and good in dense breasts. All issues for currently.
Adam Perriman
Founder and CSO of Cytoseek
Follow Adam Perriman:
About Cytoseek: For next-generation cell therapies.
